Bristol-Myers Squibb: Risk And Return
Seeking Alpha contributor Gaurao Bhade characterized Bristol-Myers Squibb (NYSE:BMY) as a high risk, high return bet for 2017, and President Trump's speech to Congress Tuesday night limned elements of risk and return for drug stocks in general. Bhade saw the chance for high returns in BMY based on a couple of factors primarily:
